Regeneron Pharmaceuticals
Regeneron is a leading biotechnology company that invents, develops, and commercializes life-transforming medicines for people with serious diseases. Learn more
Launch date
Employees
Market cap
€116.7b
Enterprise valuation
€110.2b (Public information from Sep 2024)
Share price
$1150.18994 REGN
Town of Greenburgh New York (HQ)
Corporate Venture Fund: Regeneron Ventures
Authorizing premium user...